A Clinical Trial to Evaluate the Bone Metabolism and the Blood Sugar of Evogliptin and Dapagliflozin

Clinical trial NCT04706637 · UNKNOWN

Trial details

NCT number: NCT04706637
Sponsor: Kyung Hee University Hospital at Gangdong
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Bone Diseases, Metabolic Diabetes Mellitus, Type 2

Start date: 2021-02-01
Primary completion: 2022-01-31
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.